IIMA_Brat

HCG.. Big ATH Breakout (On the way, for 500% to 1000% returns)

Long
NSE:HCG   HEALTHCARE GLOBAL
Fundamentally::

- Cheapest across the Hospital Industry, with 18x CFO to EBITDA
- Cancer care is in the great tailwind across developed economies, which makes HCG a good play for the long run. As India evolves into a developed country, or India positions itself as a medical treatment outsourcer.
- CEO is capable of envisioning a turnaround in the business

Technically::

- Highest strength across its industry peers
- Fresh breakout of all-time high, may go 5-10x from this level in 5-7 years.

Disclaimer:: Biased.
#Very_high_Skin_in_the_game!
Clause de non-responsabilité

Les informations et les publications ne sont pas destinées à être, et ne constituent pas, des conseils ou des recommandations en matière de finance, d'investissement, de trading ou d'autres types de conseils fournis ou approuvés par TradingView. Pour en savoir plus, consultez les Conditions d'utilisation.